Download PDF
CC BY 4.0 · World J Nucl Med 2024; 23(02): 135-140
DOI: 10.1055/s-0044-1779747
Case Report

Bone Metastasis from Renal Cancer Coinciding with the Same Anatomical Position as a Vertebral Hemangioma: A Collision Lesion Case Report

André Marcondes Braga Ribeiro 
1   Department of Nuclear Medicine A.C.Camargo Cancer Center, São Paulo, SP, Brazil
,
Amanda Silles Borin
1   Department of Nuclear Medicine A.C.Camargo Cancer Center, São Paulo, SP, Brazil
,
Guilherme Dias Rocha de Mello
1   Department of Nuclear Medicine A.C.Camargo Cancer Center, São Paulo, SP, Brazil
,
Rubens Chojniak
2   Department of Radiology, A.C.Camargo Cancer Center, São Paulo, SP, Brazil
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Collisions lesions are rare neoplasms where two histologically distinct tumors coexist in the same organ or anatomical site. Vertebral hemangiomas (VHs) are the most common lesions involving the vertebral bodies and imaging findings of typical and atypical hemangiomas, variant forms of hemangioma such as aggressive hemangiomas are well known, but collision lesions involving VHs are extremely rare. This article presents a case report of a 73-year-old male patient diagnosed with clear cell renal cancer in a rare presentation of a bone metastasis coinciding with the same anatomical position as a VH (collision lesion). This required a multidisciplinary approach involving various diagnostic techniques to determine the best therapeutic management.

Keywords

bone metastasis - collision lesion - FDG - PET/CT - renal cancer - vertebral hemangioma

Informed Consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published, and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.


Authors' Contributions

A.M.B.R. was involved in conceptualization, patient consent, ethical approval, drafting manuscript, supervision, critical revision, and final approval. A.S.B. helped in data collection, analysis and interpretation, and drafting manuscript. G.D.R.M. contributed to data collection, analysis and interpretation, and drafting manuscript. R.C. helped in conceptualization and critical revision.




Publication History

Article published online:
28 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
    CrossrefPubMedGoogle Scholar
  • 2 Tran J, Ornstein MC. Clinical review on the management of metastatic renal cell carcinoma. JCO Oncol Pract 2022; 18 (03) 187-196
    CrossrefPubMedGoogle Scholar
  • 3 Motzer RJ, Hutson TE, Tomczak P. et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356 (02) 115-124
    CrossrefPubMedGoogle Scholar
  • 4 Motzer RJ. Memorial Sloan Kettering Cancer Center Þ, Jonasch E, Agarwal N, Alva A, Bagshaw H, et al. NCCN Guidelines Version 1.2024 Kidney Cancer Continue NCCN Guidelines Panel Disclosures [Internet]. 2023. Accessed January 26, 2023 at: https://www.nccn.org/home/member-
  • 5 Barcelos VHP, Martins KAM, de Mendonça PHF, Barros RJR. Comparative study between image obtaining techniques in the diagnostic of renal cell carcinoma. Research, Society and Development 2022; Sep 22;11(12):e493111234676
    Google Scholar
  • 6 Nigro L, Donnarumma P. Vertebral hemangiomas: common lesions with still many unknown aspects. J Spine Surg 2017; 3 (02) 309-311
    CrossrefPubMedGoogle Scholar
  • 7 Hegde G, Azzopardi C, Davies AM, Patel A, James SL, Botchu R. Spinal collision lesions. J Clin Orthop Trauma 2021; 19: 21-25
    CrossrefPubMedGoogle Scholar
  • 8 Alfawareh M, Alotaibi T, Labeeb A, Audat Z. A symptomatic case of thoracic vertebral hemangioma causing lower limb spastic paresis. Am J Case Rep 2016; 17: 805-809
    CrossrefPubMedGoogle Scholar
  • 9 Cox M, Ramchand P, Sedora-Roman NI, Frank DM, Kung D, Pukenas BA. Lymphoma metastasis to vertebral body hemangioma: collision tumor causing cord compression. World Neurosurg 2019; 132: 53-56
    CrossrefPubMedGoogle Scholar
  • 10 Zapałowicz K, Bierzyńska-Macyszyn G, Stasiów B, Krzan A, Wierzycka B, Kopycka A. Vertebral hemangioma coincident with metastasis of colon adenocarcinoma. J Neurosurg Spine 2016; 24 (03) 506-509
    CrossrefPubMedGoogle Scholar
  • 11 Zerlauth JB, Meuli R, Dunet V. Renal cell carcinoma metastasis involving vertebral hemangioma: dual percutaneous treatment by navigational bipolar radiofrequency ablation and high viscosity cement vertebroplasty. J Neurointerv Surg 2017; 9 (09) e34-e34
    CrossrefPubMedGoogle Scholar
  • 12 Gaudino S, Martucci M, Colantonio R. et al. A systematic approach to vertebral hemangioma. Skeletal Radiol 2015; 44 (01) 25-36
    CrossrefPubMedGoogle Scholar
  • 13 Pozzessere C, Bassanelli M, Ceribelli A. et al. Renal cell carcinoma: the oncologist asks, can PSMA PET/CT answer?. Curr Urol Rep 2019; 20 (11) http://link.springer.com/10.1007/s11934-019-0938-9 [Internet] 68
    CrossrefPubMedGoogle Scholar
  • 14 Ma H, Shen G, Liu B, Yang Y, Ren P, Kuang A. Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma: a systematic review and meta-analysis. Nucl Med Commun 2017; 38 (02) 156-163
    CrossrefPubMedGoogle Scholar
  • 15 Nakayama M, Okizaki A, Ishitoya S, Aburano T. “Hot” vertebra on (18)F-FDG PET scan: a case of vertebral hemangioma. Clin Nucl Med 2012; 37 (12) 1190-1193
    CrossrefPubMedGoogle Scholar
  • 16 Elhelf IAS, Pillenahalli Maheshwarappa R, Hodgson J, Hodgson CK, Pollard J, Menda Y. Giant vertebral hemangioma masquerading as aggressive tumor: Tc-99m tagged RBC scan can help to solve the diagnostic conundrum!. Radiol Case Rep 2019; 14 (11) 1360-1363
    CrossrefPubMedGoogle Scholar
  • 17 Hofman MS, Lawrentschuk N, Francis RJ. et al; proPSMA Study Group Collaborators. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 2020; 395 (10231): 1208-1216
    CrossrefPubMedGoogle Scholar
  • 18 Ahn T, Roberts MJ, Abduljabar A. et al. A review of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) in renal cell carcinoma (RCC). Mol Imaging Biol 2019; 21 (05) http://link.springer.com/10.1007/s11307-018-01307-0 [Internet] 799-807
    CrossrefPubMedGoogle Scholar
  • 19 Rizzo A, Racca M, Dall'Armellina S. et al. The emerging role of PET/CT with PSMA-Targeting radiopharmaceuticals in clear cell renal cancer: an updated systematic review. Cancers (Basel) 2023; 15 (02) 355
    CrossrefPubMedGoogle Scholar